Medicinal CBD Experience Capabilities
The efforts of the last two decades of scientist facilitating the fact based, scientific approach to understanding the human endocannabinoid system (ECS) and the receptors (CB1, CB2) are driving the recognition of the impact of the this system modulating disease and health. Evidence of the ECS system as a target in treating extremely common diseases such as; chronic pain, migraines, neurodegenerative disease, epilepsy, anorexia, bulimia and gastrointestinal disorders continues to mount.
LCN Consulting has over 15 years of experience conducting market research with healthcare professionals at every level and converting data into actionable decision making analysis.
We are uniquely positioned to assist in your research needs in the medical CBD category due to our established relationships with other science and date driven groups committed to understanding the impact on the healthcare market, patients and healthcare providers.